Senior Scientist, Multiomics

Johnson & Johnson Johnson & Johnson · Pharma · Cambridge, MA +2

Seeking a Senior Scientist to develop mechanistic insights from phenotypic assays based in spatial omics disease maps. The role involves leading the development of high-throughput cellular assay platforms for discovery efforts in immunology, neuroscience, and oncology. Requires expertise in designing genetic libraries, implementing CRISPR-based perturbation strategies, and building engineered cell systems. The position also involves cross-training in spatial omics technologies.

What you'd actually do

  1. Design, construct, and optimize genetic libraries for CRISPR-based perturbation, reporter assays, over-expression systems and multiplexed functional studies.
  2. Develop and execute complex phenotypic assays, including high‑content imaging, pooled optical screens, and massively parallel reporter assays (MPRA).
  3. Engineer and characterize advanced cellular models, including an emphasis on immune cells and models relevant to immunology, neuroscience, and oncology.
  4. Establish and optimize FACS-based workflows, including sorting strategies, multicolor panel design, and high-throughput cell processing.
  5. Implement and refine pooled and arrayed screening platforms, ensuring robust delivery, expression, and representation of perturbation libraries.

Skills

Required

  • PhD in Genetics, Genomics, Molecular Biology, Cell Biology, Systems biology, Human biology or a related discipline
  • Post-doctoral fellowship in a related field or equivalent industry experience
  • 3 years of biotech or pharmaceutical industry experience OR post-doctoral / academic staff scientist experience in a deeply technical role
  • Strong track record of high-impact scientific delivery

Nice to have

  • Experience with immune cells
  • Experience with iPSCs, organoids, co-culture systems, and cell-printing technologies
  • Prior experience in spatial omics
  • Basic computational skills for library design, data exploration, quality control, and visualization

What the JD emphasized

  • CRISPR‑based perturbation strategies
  • building engineered cell systems
  • spatial omics technologies